Interstitial cystitis (chronic) with hematuria
Methodology & AI Transparency ⓘ
Interstitial cystitis (chronic) with hematuria Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Interstitial cystitis (chronic) with hematuria is an ICD-10-CM indexed diagnosis (N30.11) within Prostate (BPH), Bladder & Urinary Tract.
- 2 Real-world patient consensus: Mapped to Prostate (BPH), Bladder & Urinary Tract under ICD-10-CM N30.11 for Interstitial cystitis (chronic) with hematuria clinical workups.
- 3 Typical cash cost range: Workup highlights for Interstitial cystitis (chronic) with hematuria (N30.11): pelvic-floor/detrusor retraining [Interstitial cystitis (chronic) with hematuria N30.11].
- 4 Top reported side effects / signs: Key Urology & Prostate biomarkers for Interstitial cystitis (chronic) with hematuria (N30.11): Total PSA & in Interstitial cystitis (chronic) with hematuria (N30.11: Serum Creatinine/eGFR) & IPSS Urinary Symptom in Interstitial cystitis (chronic) with hematuria (N30.11: Score) (0 – 7 (mild symptoms) (N30.11)).
Ask our AI Specialists anything about Interstitial cystitis (chronic) with hematuria
What Is Interstitial cystitis (chronic) with hematuria?
Interstitial cystitis (chronic) with hematuria is an ICD-10-CM indexed diagnosis (N30.11) within Prostate (BPH), Bladder & Urinary Tract. Clinical evaluation centers on pelvic-floor/detrusor retraining [Interstitial cystitis (chronic) with hematuria N30.11] alongside serial Total PSA & in Interstitial cystitis (chronic) with hematuria (N30.11: Serum Creatinine/eGFR) tracking (Age-specific PSA; eGFR > 75 mL/min (N30.11)) to guide individualized care.
Pathophysiology, Underlying Causes & Clinical Presentation
Biological expression of Interstitial cystitis (chronic) with hematuria (N30.11, Urology & Prostate) reflects alpha-1A adrenergic smooth-muscle in Interstitial cystitis (chronic) with hematuria (N30.11: tone narrowing the). longitudinal control is benchmarked via Total PSA & in Interstitial cystitis (chronic) with hematuria (N30.11: Serum Creatinine/eGFR).
Common Symptoms & Clinical Signs
- • Presentation of Interstitial cystitis (chronic) with hematuria (N30.11): burning dysuria, suprapubic in Interstitial cystitis (chronic) with hematuria (N30.11: discomfort, or cloudy/hematuric)
- • Secondary Interstitial cystitis (chronic) with hematuria clinical sign: sudden severe flank-to-groin in Interstitial cystitis (chronic) with hematuria (N30.11: colicky pain caused)
- • Symptom flares in Interstitial cystitis (chronic) with hematuria correlating with Total PSA & in Interstitial cystitis (chronic) with hematuria (N30.11: Serum Creatinine/eGFR) deviation outside Age-specific PSA; eGFR > 75 mL/min (N30.11)
- • Functional urology & prostate impact requiring pelvic-floor/detrusor retraining [Interstitial cystitis (chronic) with hematuria N30.11] evaluation (N30.11)
Interstitial cystitis (chronic) with hematuria Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | N30.11 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Prostate (BPH), Bladder & Urinary Tract | NLM Clinical Tables |
| Diagnostic / Lab Marker: Total PSA & in Interstitial cystitis (chronic) with hematuria (N30.11: Serum Creatinine/eGFR) | Age-specific PSA; eGFR > 75 mL/min (N30.11) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: IPSS Urinary Symptom in Interstitial cystitis (chronic) with hematuria (N30.11: Score) | 0 – 7 (mild symptoms) (N30.11) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Urinalysis & Post-Void in Interstitial cystitis (chronic) with hematuria (N30.11: Residual (PVR)) | Negative leukocyte/nitrite; PVR < 50 mL (N30.11) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Interstitial cystitis (chronic) with hematuria
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Erythromycin Topical Solution 2% Erythromycin Topical Solution 2% Generic • RxCUI RXN-71656030-3230 | Macrolide | 74% | $0.3361 | $ 22.11 /mo |
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Interstitial cystitis (chronic) with hematuria)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Tadalafil on lower urinary tract symptoms secondary to benign prostatic: What a 505-Participant Study Found Tadalafil was efficacious and well tolerated in treating ED and LUTS/BPH in sexually active men with both conditions. The journal of sexual medicine • 2013-08-15 • Randomized Controlled Trial | N = 505 | 93/100 | PMID 23782459 ↗ |
| New Insights on Reversal of Pharmacologically Induced Mydriasis with Phentolamine Ophthalmic: What a 553-Participant Study Found Treatment with POS reduced PD within 60 to 90 minutes, with a statistically significant time savings of 5 to 6 hours to return to baseline PD compared with placebo. Ophthalmology • 2025-01-15 • Phase III Randomized Trial | N = 553 | 93/100 | PMID 39293681 ↗ |
| Can This Approach Help? Inside the Latest Research on Outcomes in Systemic Sclerosis-Associated Interstitial Lung Disease Based on These analyses of data from the SENSCIS trial suggest that patients with SSc-ILD who are ACA positive or ARA positive can experience progression of SSc-ILD. The Journal of rheumatology • 2025-09-01 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 40233987 ↗ |
| Can This Approach Help? Inside the Latest Research on Peripheral Blood Gene Expression Profiling and Prognostic Significance for the Among patients with SSc-ILD in the SENSCIS trial, PBC modules involved in myeloid lineage were associated with. Arthritis & rheumatology (Hoboken, N.J.) • 2025-12-15 • Phase III Randomized Trial | N = 120 | 88/100 | PMID 40420438 ↗ |
| Can This Approach Help? Inside the Latest Research on Benefits and safety of tocilizumab in Japanese patients with systemic sclerosis The real-world benefits and safety of tocilizumab in patients with systemic sclerosis were consistent between the Japanese subpopulation and the global trial population. Modern rheumatology • 2024-03-28 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 37436828 ↗ |
Interstitial cystitis (chronic) with hematuria Patient Community & “People Like Me” Threads
Filter Interstitial cystitis (chronic) with hematuria community threads and patient logs by age, biological sex, dosage, and treatment duration.